HRES 68 is a symbolic resolution supporting National Catholic Schools Week, which recognizes Catholic schools' educational and community contributions. It does not create new policies or funding but formally endorses the week's goals - highlighting Catholic schools' academic achievements, diverse student enrollment, and role in fostering moral development. The resolution was introduced by multiple House members and passed without opposition, focusing on acknowledgment rather than legislative action. It directly affects Catholic schools by affirming their nationwide impact, though it has no binding effect on federal programs or resources.
This bill would prohibit the FDA from approving new abortion medications or investigational uses of existing ones. It would restrict currently approved abortion drugs to in-person administration only in clinics, hospitals, or medical offices by certified providers who can handle complications like ectopic pregnancy or severe bleeding. The law requires detailed adverse event reporting (excluding patient identifiers) to the FDA by both manufacturers and prescribers, and mandates provider certification covering pregnancy assessment, surgical intervention capabilities, and patient safety documentation. These provisions apply directly to healthcare providers, patients seeking medication abortions, and manufacturers of abortion drugs.
This bill nullifies certain changes made by the Food and Drug Administration (FDA) to dispensing requirements for mifepristone. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.) The FDA regulates the use of mifepristone through the Mifepristone Risk Evaluation and Mitigation Strategy (REMS) program. The program requires health care providers to comply with certain requirements in order to prescribe or dispense mifepristone to end a pregnancy; the program previously included an in-person dispensing requirement that required mifepristone to be directly dispensed to patients in clinics, medical offices, or hospitals. During the COVID-19 public health emergency, the FDA temporarily stopped enforcing the in-person dispensing requirement, which allowed mail-order pharmacies to fill and dispense mifepristone prescriptions. In January 2023, the FDA modified program requirements so as to (1) remove the in-person dispensing requirement, and (2) require pharmacies to be certified in the program in order to dispense mifepristone. The modifications allow retail pharmacies, after receiving certification, to dispense mifepristone pursuant to prescriptions that are written by program-certified prescribers. The bill nullifies the January 2023 changes and prohibits any similar changes in the future.
Protecting Life from Chemical Abortions Act This bill nullifies certain changes made by the Food and Drug Administration (FDA) to dispensing requirements for mifepristone. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.) The FDA regulates the use of mifepristone through the Mifepristone Risk Evaluation and Mitigation Strategy (REMS) program. The program requires health care providers to comply with certain requirements in order to prescribe or dispense mifepristone to end a pregnancy; the program previously included an in-person dispensing requirement that required mifepristone to be directly dispensed to patients in clinics, medical offices, or hospitals. During the COVID-19 public health emergency, the FDA temporarily stopped enforcing the in-person dispensing requirement, which allowed mail-order pharmacies to fill and dispense mifepristone prescriptions. In January 2023, the FDA modified program requirements so as to (1) remove the in-person dispensing requirement, and (2) require pharmacies to be certified in the program in order to dispense mifepristone. The modifications allow retail pharmacies, after receiving certification, to dispense mifepristone pursuant to prescriptions that are written by program-certified prescribers. The bill nullifies the January 2023 changes and prohibits the FDA from (1) exercising any enforcement discretion with respect to program requirements, or (2) reducing program protections until every state submits certain data regarding abortions to the Centers for Disease Control and Prevention. The bill also generally prohibits the declaration of a public health emergency with respect to abortions.
The Educational Choice for Children Act creates tax credits for individuals and corporations that contribute to scholarship organizations providing educational scholarships. Individuals can claim a credit up to 10% of their adjusted gross income or $5,000, while corporations can claim up to 5% of taxable income. Scholarships are available to students in households earning no more than 300% of the area median income and can be used for public or private school expenses, including religious schools. The bill establishes a $10 billion annual cap on total contributions with funds allocated on a first-come, first-served basis, and requires scholarship organizations to verify student income and distribute scholarships to multiple students. It also prohibits government control over scholarship organizations and schools, ensuring maximum freedom for these organizations.
The A PLUS Act (S 110) allows states to consolidate federal education funds under a "declaration of intent," giving them flexibility to manage programs like Title I under the Elementary and Secondary Education Act (ESEA) while reducing administrative burdens. States must submit a declaration outlining eligible programs, commit to using funds to supplement state funding (not replace it), and report annually on student progress to parents and taxpayers. Key provisions include limiting administrative costs to 1% of consolidated funds (or 3% if excluding Title I), requiring accountability for disadvantaged students, and prohibiting consolidation of Individuals with Disabilities Education Act (IDEA) funds. The bill directly affects states, local school districts, and parents through streamlined fund use and transparency requirements.
This bill prohibits the FDA from approving new abortion drugs and restricts existing approved drugs to in-person administration by certified healthcare providers. It requires providers to be certified in pregnancy assessment, ectopic pregnancy diagnosis, and emergency care capabilities, and mandates that drugs can only be dispensed in clinics, offices, or hospitals. The bill also imposes new reporting requirements for adverse events (like hospitalizations or severe infections) and requires providers to document risks to patients before prescribing. These provisions apply to all drugs defined as "abortion drugs" under the bill, which includes any substance intended to terminate pregnancy (excluding specific medical exceptions).
HR 564 redirects unspent funds from the American Rescue Plan Act of 2021 (ARP) to reduce the federal deficit. It requires all unobligated ARP funds - money allocated but not yet spent - to be sent to the Treasury's general fund upon the bill's enactment. This action directly affects federal budget accounting by canceling unused appropriations rather than creating new programs or aiding specific groups. The bill does not alter existing laws or services but focuses solely on reallocating existing, unspent federal funds. It is a procedural budget measure with no direct impact on taxpayers or beneficiaries of the ARP.
The Educational Choice for Children Act creates tax credits for individuals and corporations that contribute to scholarship granting organizations providing education scholarships. Individuals can claim a credit up to $5,000 or 10% of their income, while corporations can claim up to 5% of taxable income. The scholarships are available to students from households with income up to 300% of the area median income, and can be used for private school tuition, tutoring, and other educational expenses at elementary and secondary schools. The bill includes strict requirements for scholarship organizations to verify income, conduct audits, and prevent misuse of funds, while also prohibiting government control over these organizations and protecting private and religious schools from discrimination in the program. It establishes a $10 billion annual cap on the total tax credits available.
This bill prohibits federal funds from covering abortions in most circumstances, including health benefits plans, with exceptions for cases of rape, incest, or when a pregnancy endangers a woman's life. It specifically bars the use of Affordable Care Act (ACA) premium tax credits and cost-sharing reductions for health plans that cover abortion, requiring insurers to disclose abortion coverage details separately in marketing materials. The law applies to all federal health programs and ACA marketplace plans, ensuring taxpayer dollars aren't used for abortion services or coverage. It does not affect private insurance plans purchased with non-federal funds or separate abortion coverage options.
Lifting Local Communities Act This bill specifies that government entities may not discriminate against religious organizations when awarding federal funds for social services programs (i.e., government programs that provide services for low-income individuals and communities, such as child care, transportation, employment, housing, and meal services). Specifically, religious organizations are eligible to apply for and receive federal funds to provide services for social services programs on the same basis as private, nonreligious organizations. Additionally, government entities may not discriminate against private organizations on the basis of religion when selecting funding recipients. Organizations that receive federal funds for social services programs may not discriminate against individuals on the basis of religion when providing services. If an individual objects to the character or affiliation of a private organization that is providing a service as part of a social services program, government entities must provide the individual with reasonable alternatives. Religious organizations may bring civil actions against entities for violations.
S 78 requires physicians performing abortions on minors from out-of-state to provide at least 24 hours' written notice to the minor's parent before the procedure, unless specific exceptions apply. It prohibits transporting minors across state lines to bypass parental involvement laws in their home state, with penalties for violations. Exceptions include life-threatening medical conditions, compliance with the minor's home state's abortion laws, or documented court authorization. The bill directly affects minors seeking out-of-state abortions, their parents, and medical providers who perform such procedures.
